SAFETY DATA SHEET

Sevoflurane

Section 1. Identification
GHS product identifier : Sevoflurane
Chemical name : sevoflurane
Other means of : Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-
identification
Product use : Synthetic/Analytical chemistry.
Synonym : Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-
SDS # : 001210
Supplier's details : Airgas USA, LLC and its affiliates
259 North Radnor-Chester Road
Suite 100
Radnor, PA 19087-5283
1-610-687-5253

24-hour telephone : 1-866-734-3438

Section 2. Hazards identification

OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard
(29 CFR 1910.1200).
Classification of the : SKIN CORROSION/IRRITATION - Category 2
substance or mixture SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A
TOXIC TO REPRODUCTION (Fertility) - Category 2
TOXIC TO REPRODUCTION (Unborn child) - Category 2
SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) -
Category 3

GHS label elements

Hazard pictograms :

Signal word : Warning

Hazard statements : May displace oxygen and cause rapid suffocation.
Causes serious eye irritation.
Causes skin irritation.
Suspected of damaging fertility or the unborn child.
May cause drowsiness and dizziness.
Precautionary statements
General : Read and follow all Safety Data Sheets (SDS’S) before use. Read label before use.
Keep out of reach of children. If medical advice is needed, have product container or
label at hand. Close valve after each use and when empty. Use equipment rated for
cylinder pressure. Do not open valve until connected to equipment prepared for use.
Use a back flow preventative device in the piping. Use only equipment of compatible
materials of construction.
Prevention : Obtain special instructions before use. Do not handle until all safety precautions have
been read and understood. Wear protective gloves. Wear eye or face protection.
Wear protective clothing. Use only outdoors or in a well-ventilated area. Avoid
breathing vapor. Wash hands thoroughly after handling.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 1/11
Sevoflurane

Section 2. Hazards identification

Response : IF exposed or concerned: Get medical attention. IF INHALED: Remove person to
fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if
you feel unwell. IF ON SKIN: Wash with plenty of soap and water. Take off
contaminated clothing and wash it before reuse. If skin irritation occurs: Get medical
attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get
medical attention.
Storage : Store locked up.
Disposal : Dispose of contents and container in accordance with all local, regional, national and
international regulations.
Hazards not otherwise : In addition to any other important health or physical hazards, this product may displace
classified oxygen and cause rapid suffocation.

Section 3. Composition/information on ingredients

Substance/mixture : Substance
Chemical name : sevoflurane
Other means of : Ether, fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl-
identification

CAS number/other identifiers

CAS number : 28523-86-6
Product code : 001210
Ingredient name % CAS number
sevoflurane 100 28523-86-6
Any concentration shown as a range is to protect confidentiality or is due to batch variation.
There are no additional ingredients present which, within the current knowledge of the supplier and in the
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting
in this section.
Occupational exposure limits, if available, are listed in Section 8.

Section 4. First aid measures

Description of necessary first aid measures
Eye contact : Immediately flush eyes with plenty of water, occasionally lifting the upper and lower
eyelids. Check for and remove any contact lenses. Continue to rinse for at least 10
minutes. Get medical attention.
Inhalation : Remove victim to fresh air and keep at rest in a position comfortable for breathing. If it
is suspected that fumes are still present, the rescuer should wear an appropriate mask
or self-contained breathing apparatus. If not breathing, if breathing is irregular or if
respiratory arrest occurs, provide artificial respiration or oxygen by trained personnel. It
may be dangerous to the person providing aid to give mouth-to-mouth resuscitation.
Get medical attention. If necessary, call a poison center or physician. If unconscious,
place in recovery position and get medical attention immediately. Maintain an open
airway. Loosen tight clothing such as a collar, tie, belt or waistband. In case of
inhalation of decomposition products in a fire, symptoms may be delayed. The exposed
person may need to be kept under medical surveillance for 48 hours.
Skin contact : Flush contaminated skin with plenty of water. Remove contaminated clothing and
shoes. Continue to rinse for at least 10 minutes. Get medical attention. Wash clothing
before reuse. Clean shoes thoroughly before reuse.
Ingestion : As this product is a gas, refer to the inhalation section.

Most important symptoms/effects, acute and delayed

Potential acute health effects
Eye contact : Causes serious eye irritation.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 2/11
Sevoflurane

Section 4. First aid measures

Inhalation : Can cause central nervous system (CNS) depression. May cause drowsiness and
dizziness.
Skin contact : Causes skin irritation.
Frostbite : Try to warm up the frozen tissues and seek medical attention.
Ingestion : Can cause central nervous system (CNS) depression. As this product is a gas, refer to
the inhalation section.
Over-exposure signs/symptoms
Eye contact : Adverse symptoms may include the following:, pain or irritation, watering, redness
Inhalation : Adverse symptoms may include the following:, nausea or vomiting, headache,
drowsiness/fatigue, dizziness/vertigo, unconsciousness, reduced fetal weight, increase
in fetal deaths, skeletal malformations
Skin contact : Adverse symptoms may include the following:, irritation, redness, reduced fetal weight,
increase in fetal deaths, skeletal malformations
Ingestion : Adverse symptoms may include the following:, reduced fetal weight, increase in fetal
deaths, skeletal malformations

Indication of immediate medical attention and special treatment needed, if necessary

Notes to physician : In case of inhalation of decomposition products in a fire, symptoms may be delayed.
The exposed person may need to be kept under medical surveillance for 48 hours.
Specific treatments : No specific treatment.
Protection of first-aiders : No action shall be taken involving any personal risk or without suitable training. If it is
suspected that fumes are still present, the rescuer should wear an appropriate mask or
self-contained breathing apparatus. It may be dangerous to the person providing aid to
give mouth-to-mouth resuscitation.

See toxicological information (Section 11)

Section 5. Fire-fighting measures

Extinguishing media
Suitable extinguishing : Use an extinguishing agent suitable for the surrounding fire.
media
Unsuitable extinguishing : None known.
media

Specific hazards arising : Contains gas under pressure. In a fire or if heated, a pressure increase will occur and
from the chemical the container may burst or explode.
Hazardous thermal : Decomposition products may include the following materials:
decomposition products carbon dioxide
carbon monoxide
halogenated compounds
carbonyl halides

Special protective actions : Promptly isolate the scene by removing all persons from the vicinity of the incident if
for fire-fighters there is a fire. No action shall be taken involving any personal risk or without suitable
training. Contact supplier immediately for specialist advice. Move containers from fire
area if this can be done without risk. Use water spray to keep fire-exposed containers
cool.
Special protective : Fire-fighters should wear appropriate protective equipment and self-contained breathing
equipment for fire-fighters apparatus (SCBA) with a full face-piece operated in positive pressure mode.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 3/11
Sevoflurane

Section 6. Accidental release measures

Personal precautions, protective equipment and emergency procedures
For non-emergency : No action shall be taken involving any personal risk or without suitable training.
personnel Evacuate surrounding areas. Keep unnecessary and unprotected personnel from
entering. Avoid breathing gas. Provide adequate ventilation. Wear appropriate
respirator when ventilation is inadequate. Put on appropriate personal protective
equipment.
For emergency responders : If specialised clothing is required to deal with the spillage, take note of any information
in Section 8 on suitable and unsuitable materials. See also the information in "For non-
emergency personnel".

Environmental precautions : Ensure emergency procedures to deal with accidental gas releases are in place to avoid
contamination of the environment. Inform the relevant authorities if the product has
caused environmental pollution (sewers, waterways, soil or air).

Methods and materials for containment and cleaning up

Small spill : Immediately contact emergency personnel. Stop leak if without risk.
Large spill : Immediately contact emergency personnel. Stop leak if without risk. Note: see Section
1 for emergency contact information and Section 13 for waste disposal.

Section 7. Handling and storage

Precautions for safe handling
Protective measures : Put on appropriate personal protective equipment (see Section 8). Contains gas under
pressure. Avoid exposure - obtain special instructions before use. Avoid exposure
during pregnancy. Do not handle until all safety precautions have been read and
understood. Do not get in eyes or on skin or clothing. Avoid breathing gas. Use only
with adequate ventilation. Wear appropriate respirator when ventilation is inadequate.
Empty containers retain product residue and can be hazardous. Do not puncture or
incinerate container. Use equipment rated for cylinder pressure. Close valve after each
use and when empty. Protect cylinders from physical damage; do not drag, roll, slide, or
drop. Use a suitable hand truck for cylinder movement.

Advice on general : Eating, drinking and smoking should be prohibited in areas where this material is
occupational hygiene handled, stored and processed. Workers should wash hands and face before eating,
drinking and smoking. Remove contaminated clothing and protective equipment before
entering eating areas. See also Section 8 for additional information on hygiene
measures.

Conditions for safe storage, : Store in accordance with local regulations. Store in a segregated and approved area.
including any Store in a dry, cool and well-ventilated area, away from incompatible materials (see
incompatibilities Section 10). Store locked up. Keep container tightly closed and sealed until ready for
use. Cylinders should be stored upright, with valve protection cap in place, and firmly
secured to prevent falling or being knocked over. Cylinder temperatures should not
exceed 52 °C (125 °F).

Section 8. Exposure controls/personal protection

Control parameters
Occupational exposure limits
sevoflurane None.

Appropriate engineering : Use only with adequate ventilation. Use process enclosures, local exhaust ventilation or
controls other engineering controls to keep worker exposure to airborne contaminants below any
recommended or statutory limits.
Environmental exposure : Emissions from ventilation or work process equipment should be checked to ensure
controls they comply with the requirements of environmental protection legislation. In some
cases, fume scrubbers, filters or engineering modifications to the process equipment
will be necessary to reduce emissions to acceptable levels.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 4/11
Sevoflurane

Section 8. Exposure controls/personal protection

Individual protection measures

Hygiene measures : Wash hands, forearms and face thoroughly after handling chemical products, before
eating, smoking and using the lavatory and at the end of the working period.
Appropriate techniques should be used to remove potentially contaminated clothing.
Wash contaminated clothing before reusing. Ensure that eyewash stations and safety
showers are close to the workstation location.
Eye/face protection : Safety eyewear complying with an approved standard should be used when a risk
assessment indicates this is necessary to avoid exposure to liquid splashes, mists,
gases or dusts. If contact is possible, the following protection should be worn, unless
the assessment indicates a higher degree of protection: chemical splash goggles.
Skin protection
Hand protection : Chemical-resistant, impervious gloves complying with an approved standard should be
worn at all times when handling chemical products if a risk assessment indicates this is
necessary. Considering the parameters specified by the glove manufacturer, check
during use that the gloves are still retaining their protective properties. It should be
noted that the time to breakthrough for any glove material may be different for different
glove manufacturers. In the case of mixtures, consisting of several substances, the
protection time of the gloves cannot be accurately estimated.
Body protection : Personal protective equipment for the body should be selected based on the task being
performed and the risks involved and should be approved by a specialist before
handling this product.
Other skin protection : Appropriate footwear and any additional skin protection measures should be selected
based on the task being performed and the risks involved and should be approved by a
specialist before handling this product.
Respiratory protection : Use a properly fitted, air-purifying or air-fed respirator complying with an approved
standard if a risk assessment indicates this is necessary. Respirator selection must be
based on known or anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator.

Section 9. Physical and chemical properties

Appearance
Physical state : Liquid.
Color : Colorless.
Molecular weight : 200.07 g/mole
Molecular formula : C4-H3-F7-O
Boiling/condensation point : 58.5°C (137.3°F)
Critical temperature : Not available.

Odor : Characteristic.
Odor threshold : Not available.
pH : Not available.
Flash point : [Product does not sustain combustion.]
Burning time : Not applicable.
Burning rate : Not applicable.
Evaporation rate : Not available.
Flammability (solid, gas) : Not available.
Lower and upper explosive : Not available.
(flammable) limits
Vapor pressure : 21 kPa (157.512797914 mm Hg) [room temperature]
Vapor density : Not available.
Specific Volume (ft /lb) 3
: 18.2482
Gas Density (lb/ft ) 3
: 0.0548
Relative density : 1.525

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 5/11
Sevoflurane

Section 9. Physical and chemical properties

Solubility : Not available.
Solubility in water : Not available.
Partition coefficient: n- : 1.75
octanol/water
Auto-ignition temperature : Not available.
Decomposition temperature : Not available.
SADT : Not available.
Viscosity : Not available.

Section 10. Stability and reactivity

Reactivity : No specific test data related to reactivity available for this product or its ingredients.

Chemical stability : The product is stable.

Possibility of hazardous : Under normal conditions of storage and use, hazardous reactions will not occur.
reactions

Conditions to avoid : No specific data.

Incompatible materials : No specific data.

Hazardous decomposition : Under normal conditions of storage and use, hazardous decomposition products should
products not be produced.

Conditions of instability : Under normal conditions of storage and use, hazardous polymerization will not occur.

Hazardous polymerization : Under normal conditions of storage and use, hazardous polymerization will not occur.

Section 11. Toxicological information

Information on toxicological effects
Acute toxicity
Product/ingredient name Result Species Dose Exposure
sevoflurane LC50 Inhalation Gas. Rat 58000 ppm 1 hours
LD50 Oral Rat 10800 mg/kg -
Irritation/Corrosion
Not available.
Sensitization
Not available.
Mutagenicity
Not available.
Carcinogenicity
Not available.
Reproductive toxicity
Not available.
Teratogenicity
Not available.
Specific target organ toxicity (single exposure)

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 6/11
Sevoflurane

Section 11. Toxicological information

Name Category Route of Target organs
exposure
sevoflurane Category 3 Not applicable. Narcotic effects
Specific target organ toxicity (repeated exposure)
Not available.

Aspiration hazard
Not available.

Information on the likely : Routes of entry anticipated: Inhalation.

routes of exposure
Potential acute health effects
Eye contact : Causes serious eye irritation.
Inhalation : Can cause central nervous system (CNS) depression. May cause drowsiness and
dizziness.
Skin contact : Causes skin irritation.
Ingestion : Can cause central nervous system (CNS) depression. As this product is a gas, refer to
the inhalation section.

Symptoms related to the physical, chemical and toxicological characteristics

Eye contact : Adverse symptoms may include the following:, pain or irritation, watering, redness
Inhalation : Adverse symptoms may include the following:, nausea or vomiting, headache,
drowsiness/fatigue, dizziness/vertigo, unconsciousness, reduced fetal weight, increase
in fetal deaths, skeletal malformations
Skin contact : Adverse symptoms may include the following:, irritation, redness, reduced fetal weight,
increase in fetal deaths, skeletal malformations
Ingestion : Adverse symptoms may include the following:, reduced fetal weight, increase in fetal
deaths, skeletal malformations

Delayed and immediate effects and also chronic effects from short and long term exposure
Short term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Long term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Potential chronic health effects
Not available.
General : No known significant effects or critical hazards.
Carcinogenicity : No known significant effects or critical hazards.
Mutagenicity : No known significant effects or critical hazards.
Teratogenicity : Suspected of damaging the unborn child.
Developmental effects : No known significant effects or critical hazards.
Fertility effects : Suspected of damaging fertility.

Numerical measures of toxicity

Acute toxicity estimates
Not available.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 7/11
Sevoflurane

Section 11. Toxicological information

Section 12. Ecological information

Toxicity
Not available.

Persistence and degradability

Not available.

Bioaccumulative potential
Product/ingredient name LogPow BCF Potential
sevoflurane 1.75 - low

Mobility in soil
Soil/water partition : Not available.
coefficient (KOC)

Other adverse effects : No known significant effects or critical hazards.

Section 13. Disposal considerations

Disposal methods : The generation of waste should be avoided or minimized wherever possible. Disposal
of this product, solutions and any by-products should at all times comply with the
requirements of environmental protection and waste disposal legislation and any
regional local authority requirements. Dispose of surplus and non-recyclable products
via a licensed waste disposal contractor. Waste should not be disposed of untreated to
the sewer unless fully compliant with the requirements of all authorities with jurisdiction.
Empty Airgas-owned pressure vessels should be returned to Airgas. Waste packaging
should be recycled. Incineration or landfill should only be considered when recycling is
not feasible. This material and its container must be disposed of in a safe way. Empty
containers or liners may retain some product residues. Do not puncture or incinerate
container.

Section 14. Transport information

DOT TDG Mexico IMDG IATA
UN number UN3334 UN3334 UN3334 UN3334 UN3334
UN proper Aviation regulated Aviation regulated Aviation regulated Aviation regulated Aviation regulated
liquid, N.O.S. liquid, n.o.s. liquid, N.O.S. liquid, n.o.s. liquid, N.O.S.
shipping name (sevoflurane) (sevoflurane) (sevoflurane) (sevoflurane) (sevoflurane)

Transport 9 9 9 9 9
hazard class(es)

Packing group III III III III III

Environment No. No. No. No. No.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 8/11
Sevoflurane

Section 14. Transport information

Additional Special provisions Product classified as - - -
A35 - This includes any per the following
information sections of the
material which is not
covered by any of the Transportation of
other classes but which Dangerous Goods
has Regulations: 2.43-2.45
an anesthetic, narcotic, (Class 9).
noxious or other similar
properties such that, in
the event of spillage or
leakage on an aircraft,
extreme annoyance or
discomfort could be
caused to crew
members so
as to prevent the
correct performance of
assigned duties.

“Refer to CFR 49 (or authority having jurisdiction) to determine the information required for shipment of the
product.”

Special precautions for user : Transport within user’s premises: always transport in closed containers that are
upright and secure. Ensure that persons transporting the product know what to do in the
event of an accident or spillage.

Transport in bulk according : Not available.

to Annex II of MARPOL
73/78 and the IBC Code

Section 15. Regulatory information

U.S. Federal regulations : TSCA 8(a) CDR Exempt/Partial exemption: Not determined
United States inventory (TSCA 8b): Not determined.

Clean Air Act Section 112 : Not listed

(b) Hazardous Air
Pollutants (HAPs)
Clean Air Act Section 602 : Not listed
Class I Substances
Clean Air Act Section 602 : Not listed
Class II Substances
DEA List I Chemicals : Not listed
(Precursor Chemicals)
DEA List II Chemicals : Not listed
(Essential Chemicals)
SARA 302/304
Composition/information on ingredients
No products were found.
SARA 304 RQ : Not applicable.
SARA 311/312
Classification : Immediate (acute) health hazard
Delayed (chronic) health hazard
Composition/information on ingredients
Name % Fire Sudden Reactive Immediate Delayed
hazard release of (acute) (chronic)
pressure health health
hazard hazard
sevoflurane 100 No. No. No. Yes. Yes.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 9/11
Sevoflurane

Section 15. Regulatory information

State regulations
Massachusetts : This material is not listed.
New York : This material is not listed.
New Jersey : This material is not listed.
Pennsylvania : This material is not listed.
International regulations
International lists
National inventory
Australia : Not determined.
Canada : Not determined.
China : Not determined.
Europe : Not determined.
Japan : This material is listed or exempted.
Malaysia : Not determined.
New Zealand : Not determined.
Philippines : Not determined.
Republic of Korea : Not determined.
Taiwan : This material is listed or exempted.
Canada
WHMIS (Canada) : Not controlled under WHMIS (Canada).
CEPA Toxic substances: This material is not listed.
Canadian ARET: This material is not listed.
Canadian NPRI: This material is not listed.
Alberta Designated Substances: This material is not listed.
Ontario Designated Substances: This material is not listed.
Quebec Designated Substances: This material is not listed.

Section 16. Other information

Canada Label requirements : Not controlled under WHMIS (Canada).
Hazardous Material Information System (U.S.A.)
Health 2

Flammability 0
Physical hazards 0

Caution: HMIS® ratings are based on a 0-4 rating scale, with 0 representing minimal hazards or risks, and 4
representing significant hazards or risks Although HMIS® ratings are not required on SDSs under 29 CFR 1910.
1200, the preparer may choose to provide them. HMIS® ratings are to be used with a fully implemented HMIS®
program. HMIS® is a registered mark of the National Paint & Coatings Association (NPCA). HMIS® materials
may be purchased exclusively from J. J. Keller (800) 327-6868.
The customer is responsible for determining the PPE code for this material.
National Fire Protection Association (U.S.A.)

0 Flammability
Health 2 0 Instability/Reactivity
Special

Reprinted with permission from NFPA 704-2001, Identification of the Hazards of Materials for Emergency
Response Copyright ©1997, National Fire Protection Association, Quincy, MA 02269. This reprinted material is
not the complete and official position of the National Fire Protection Association, on the referenced subject
which is represented only by the standard in its entirety.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 10/11
Sevoflurane

Section 16. Other information

Copyright ©2001, National Fire Protection Association, Quincy, MA 02269. This warning system is intended to
be interpreted and applied only by properly trained individuals to identify fire, health and reactivity hazards of
chemicals. The user is referred to certain limited number of chemicals with recommended classifications in
NFPA 49 and NFPA 325, which would be used as a guideline only. Whether the chemicals are classified by NFPA
or not, anyone using the 704 systems to classify chemicals does so at their own risk.
Procedure used to derive the classification
Classification Justification
Skin Irrit. 2, H315 Expert judgment
Eye Irrit. 2A, H319 Expert judgment
Repr. 2, H361 (Fertility) Expert judgment
Repr. 2, H361 (Unborn child) Expert judgment
STOT SE 3, H336 Expert judgment
History
Date of printing : 2/27/2017
Date of issue/Date of : 2/27/2017
revision
Date of previous issue : No previous validation
Version : 0.01
Key to abbreviations : ATE = Acute Toxicity Estimate
BCF = Bioconcentration Factor
GHS = Globally Harmonized System of Classification and Labelling of Chemicals
IATA = International Air Transport Association
IBC = Intermediate Bulk Container
IMDG = International Maritime Dangerous Goods
LogPow = logarithm of the octanol/water partition coefficient
MARPOL 73/78 = International Convention for the Prevention of Pollution From Ships,
1973 as modified by the Protocol of 1978. ("Marpol" = marine pollution)
UN = United Nations
References : Not available.
Indicates information that has changed from previously issued version.
Notice to reader
To the best of our knowledge, the information contained herein is accurate. However, neither the above-named
supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or completeness of the
information contained herein.
Final determination of suitability of any material is the sole responsibility of the user. All materials may present
unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot
guarantee that these are the only hazards that exist.

Date of issue/Date of revision : 2/27/2017 Date of previous issue : No previous validation Version : 0.01 11/11